283 related articles for article (PubMed ID: 25151644)
1. Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia.
Hulse RP; Beazley-Long N; Hua J; Kennedy H; Prager J; Bevan H; Qiu Y; Fernandes ES; Gammons MV; Ballmer-Hofer K; Gittenberger de Groot AC; Churchill AJ; Harper SJ; Brain SD; Bates DO; Donaldson LF
Neurobiol Dis; 2014 Nov; 71():245-59. PubMed ID: 25151644
[TBL] [Abstract][Full Text] [Related]
2. The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain.
Hulse RP; Drake RA; Bates DO; Donaldson LF
Neurobiol Dis; 2016 Dec; 96():186-200. PubMed ID: 27616424
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration.
Hulse RP; Beazley-Long N; Ved N; Bestall SM; Riaz H; Singhal P; Ballmer Hofer K; Harper SJ; Bates DO; Donaldson LF
Clin Sci (Lond); 2015 Oct; 129(8):741-56. PubMed ID: 26201024
[TBL] [Abstract][Full Text] [Related]
4. VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro.
Beazley-Long N; Hua J; Jehle T; Hulse RP; Dersch R; Lehrling C; Bevan H; Qiu Y; Lagrèze WA; Wynick D; Churchill AJ; Kehoe P; Harper SJ; Bates DO; Donaldson LF
Am J Pathol; 2013 Sep; 183(3):918-29. PubMed ID: 23838428
[TBL] [Abstract][Full Text] [Related]
5. Detection of VEGF-A(xxx)b isoforms in human tissues.
Bates DO; Mavrou A; Qiu Y; Carter JG; Hamdollah-Zadeh M; Barratt S; Gammons MV; Millar AB; Salmon AH; Oltean S; Harper SJ
PLoS One; 2013; 8(7):e68399. PubMed ID: 23935865
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-A
Pang V; Bates DO; Leach L
Clin Sci (Lond); 2017 Dec; 131(23):2763-2775. PubMed ID: 29054861
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-A
Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis.
Stevens M; Oltean S
Cells; 2019 Mar; 8(4):. PubMed ID: 30925751
[TBL] [Abstract][Full Text] [Related]
9. Sensory neuronal sensitisation occurs through HMGB-1-RAGE and TRPV1 in high-glucose conditions.
Bestall SM; Hulse RP; Blackley Z; Swift M; Ved N; Paton K; Beazley-Long N; Bates DO; Donaldson LF
J Cell Sci; 2018 Jul; 131(14):. PubMed ID: 29930087
[TBL] [Abstract][Full Text] [Related]
10. Differential Expression of VEGF-A
Barratt SL; Blythe T; Jarrett C; Ourradi K; Shelley-Fraser G; Day MJ; Qiu Y; Harper S; Maher TM; Oltean S; Hames TJ; Scotton CJ; Welsh GI; Bates DO; Millar AB
Am J Respir Crit Care Med; 2017 Aug; 196(4):479-493. PubMed ID: 28661183
[TBL] [Abstract][Full Text] [Related]
11. VEGF and its receptor-2 involved in neuropathic pain transmission mediated by P2X₂(/)₃ receptor of primary sensory neurons.
Lin J; Li G; Den X; Xu C; Liu S; Gao Y; Liu H; Zhang J; Li X; Liang S
Brain Res Bull; 2010 Oct; 83(5):284-91. PubMed ID: 20705122
[TBL] [Abstract][Full Text] [Related]
12. Functional effects of blocking VEGF/VEGFR2 signaling in the rat urinary bladder in acute and chronic CYP-induced cystitis.
Tooke K; Girard B; Vizzard MA
Am J Physiol Renal Physiol; 2019 Jul; 317(7):F43-F51. PubMed ID: 30995112
[TBL] [Abstract][Full Text] [Related]
13. Plasticity and emerging role of BKCa channels in nociceptive control in neuropathic pain.
Chen SR; Cai YQ; Pan HL
J Neurochem; 2009 Jul; 110(1):352-62. PubMed ID: 19457113
[TBL] [Abstract][Full Text] [Related]
14. The role of VEGF-A165b in trophoblast survival.
Bills VL; Hamdollah-Zadeh M; Soothill PW; Harper SJ; Bates DO
BMC Pregnancy Childbirth; 2014 Aug; 14():278. PubMed ID: 25128406
[TBL] [Abstract][Full Text] [Related]
15. Diabetes-induced microvascular complications at the level of the spinal cord: a contributing factor in diabetic neuropathic pain.
Ved N; Da Vitoria Lobo ME; Bestall SM; L Vidueira C; Beazley-Long N; Ballmer-Hofer K; Hirashima M; Bates DO; Donaldson LF; Hulse RP
J Physiol; 2018 Aug; 596(16):3675-3693. PubMed ID: 29774557
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor isoforms differentially protect neurons against neurotoxic events associated with Alzheimer's disease.
Alalwany RH; Hawtrey T; Morgan K; Morris JC; Donaldson LF; Bates DO
Front Mol Neurosci; 2023; 16():1181626. PubMed ID: 37456522
[TBL] [Abstract][Full Text] [Related]
17. SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform.
Hatcher JM; Wu G; Zeng C; Zhu J; Meng F; Patel S; Wang W; Ficarro SB; Leggett AL; Powell CE; Marto JA; Zhang K; Ki Ngo JC; Fu XD; Zhang T; Gray NS
Cell Chem Biol; 2018 Apr; 25(4):460-470.e6. PubMed ID: 29478907
[TBL] [Abstract][Full Text] [Related]
18. VEGF-A splice variants bind VEGFRs with differential affinities.
Mamer SB; Wittenkeller A; Imoukhuede PI
Sci Rep; 2020 Sep; 10(1):14413. PubMed ID: 32879419
[TBL] [Abstract][Full Text] [Related]
19. Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation.
Di Cesare Mannelli L; Tenci B; Micheli L; Vona A; Corti F; Zanardelli M; Lapucci A; Clemente AM; Failli P; Ghelardini C
Neuropharmacology; 2018 Mar; 131():166-175. PubMed ID: 29241656
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of serine/arginine-rich protein kinase-1 (SRPK1) prevents cholangiocarcinoma cells induced angiogenesis.
Supradit K; Boonsri B; Duangdara J; Thitiphatphuvanon T; Suriyonplengsaeng C; Kangsamaksin T; Janvilisri T; Tohtong R; Yacqub-Usman K; Grabowska AM; Bates DO; Wongprasert K
Toxicol In Vitro; 2022 Aug; 82():105385. PubMed ID: 35568131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
